Envestnet Portfolio Solutions
PCVX icon

Envestnet Portfolio Solutions’s Vaxcyte PCVX Stock Holding History

Envestnet Portfolio Solutions’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,278
Closed -$260K – 1778
2024
Q3 		$260K Sell
2,278
-397
-15% -$35.8K ﹤0.01% 1517
2024
Q2 		$202K Buy
+2,675
New +$182K ﹤0.01% 1587

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Portfolio Solutions's PCVX Position: Q4 2024 in Review

Envestnet Portfolio Solutions sold out of Vaxcyte (PCVX) in Q4 2024, closing a stake of 2,278 shares — an estimated $260K sold.

Envestnet Portfolio Solutions first reported a position in PCVX in Q2 2024 and held it in 2 quarters. The position peaked at $260K in Q3 2024. 323 funds tracked by Wall St. Rank hold PCVX as of Q4 2024.

  • Envestnet Portfolio Solutions reported no remaining Vaxcyte position as of Q4 2024 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 2,278 Vaxcyte shares in Q4 2024, an estimated $260K.
  • Envestnet Portfolio Solutions first reported a position in Vaxcyte in Q2 2024 and held it in 2 quarters.
  • Envestnet Portfolio Solutions's Vaxcyte position peaked at $260K in Q3 2024.
  • 323 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2024.

Based on Envestnet Portfolio Solutions's 13F filing for Q4 2024, filed 10 Feb 2025.